In another trial conducted with early-stage NSCLC patients, cytoplasmic NRF2 expression, as well as expression of its stabilizing protein DJ1, was independent prognostic factors for poorer OS [29]. Here, NFE2L2 is linked to non-small cell lung carcinoma.